Safe.Bk
SAFE.BK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, primarily generating revenue through its operations in this sector.
Business. Safehold Inc (SAFE.K) is a diversified real estate investment trust (REIT) listed on the New York Stock Exchange. The company operates within the Real Estate sector, specifically in the Diversified REITs industry, generating revenue primarily through rental income. Safehold is headquartered in the United States, though specific geographic or segment breakdowns are not provided in the available data.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Safehold Inc (SAFE.K) is a diversified real estate investment trust (REIT) listed on the New York Stock Exchange. The company operates within the Real Estate sector, specifically in the Diversified REITs industry, generating revenue primarily through rental income. Safehold is headquartered in the United States, though specific geographic or segment breakdowns are not provided in the available data.
SAFE.BK maintains a strong liquidity position, with a current ratio of 16.69, indicating a significant ability to cover short-term liabilities with its current assets. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The debt-to-equity ratio is low at 0.04, suggesting a conservative capital structure with minimal reliance on debt financing.
In terms of profitability, SAFE.BK reports a return on equity (ROE) of 7.64% and a return on assets (ROA) of 6.82%. These figures are in line with the industry's preferred metrics, indicating that the company is generating returns that are comparable to its peers. The operating margin, calculated as operating income divided by revenue, is 23.45%, which is a strong indicator of the company's operational efficiency.
The company's revenue is primarily concentrated in its core healthcare services and equipment segment, with no significant geographic diversification disclosed in the available data. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to its primary market.
Looking at the growth trajectory, SAFE.BK has demonstrated a consistent revenue performance, with a stable operating cash flow of 170.59 million THB. However, the free cash flow is negative at -18.47 million THB, which may limit the company's ability to reinvest in growth opportunities without external financing. The capital expenditure of -4.76 million THB indicates a modest investment in long-term assets, which could affect future growth potential.
The risk assessment for SAFE.BK highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is low, with no significant dilution potential identified in the basic shares outstanding. The company has not made any recent adjustments to its valuation metrics, suggesting a stable financial position.
Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The analyst estimates suggest a generally positive outlook, with a mean price target of 8.52 THB and a median price target of 8.60 THB. The mean recommendation of 2.00 indicates a neutral to slightly positive sentiment among analysts.
- SAFE.BK has a strong liquidity position with a high current ratio, but a negative net cash position introduces medium liquidity risk.
- The company's ROE and ROA are in line with industry standards, indicating solid profitability and asset utilization.
- Revenue is concentrated in the core healthcare services and equipment segment, with no significant geographic diversification.
- The company has a low debt-to-equity ratio, suggesting a conservative capital structure.
- Analysts have a generally positive outlook, with a mean price target of 8.52 THB and a median price target of 8.60 THB.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,47 |
| Revenue | —no estimate | —no estimate | 755,5M THB |
| Operating income | —no estimate | —no estimate | 195,0M THB |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- SAFE.BK Market data — financials · 2026-05-29
- Safe Fertility Group PCL Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,04 %$0M
- Investment Managers · as of 2024-06-300,00 %$170M
- Institutional Investor · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$11M
- Investment Managers · as of 2025-12-310,00 %$103M
- Investment Managers · as of 2026-03-310,00 %$36M
- Investment Managers · as of 2026-03-310,00 %$18M
- Investment Managers · as of 2026-03-310,00 %$8M
- Institutional Investor · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2024-12-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$12M
- Funds · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Jay Scott SugarmanChairman of the Board, Chief Executive Officer
Insider activity
- Chief Accounting Officer · Common StockOther 4 500 · 2026-05-29
- Director · Common StockOther 8 778 · 2026-05-14
- Director · Common StockOther 8 778 · 2026-05-14
- Director · Common StockOther 8 778 · 2026-05-14
- Director · Common StockOther 13 655 · 2026-05-14
- Director · Common StockOther 359 · 2026-04-15
- Director · Common StockOther 33 · 2026-04-15
- Director, CHAIRMAN AND CEO · Common StockOther 23 662 · 2026-03-31
- CHIEF FINANCIAL OFFICER · Common StockOther 8 118 · 2026-03-31
- CHIEF FINANCIAL OFFICER · Common StockOther 66 171 · 2026-02-27
- CHIEF FINANCIAL OFFICER · Common StockOther 27 295 · 2026-02-27
- Director, CHAIRMAN AND CEO · Common StockOther 40 825 · 2026-02-27
- Director, CHAIRMAN AND CEO · Common StockOther 90 149 · 2026-02-27
- Director · Common StockOther 362 · 2026-01-15
- Director · Common StockOther 33 · 2026-01-15
- President · Common StockOther 93 076 · 2025-12-01
- Director · Common StockOther 32 · 2025-10-15
- Director · Common StockOther 346 · 2025-10-15
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 8.1%Derived (calculated)
- Net margin (FY 2025-12-31): 29.7%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 5.4%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 5.1%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 7.4%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 12.7%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 26.3%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 6.2%Derived (calculated)
- Return on assets (FY 2025-12-31): 1.6%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 160.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 2.7%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 6.3%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 15.9%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 8.2%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 2.00xDerived (calculated)
- Return on equity (FY 2025-12-31): 4.8%Derived (calculated)
- Total assets (annual): USD 7.25BSEC XBRL filing
- Net income (annual): USD 114.47MSEC XBRL filing
- Pre-tax income (annual): USD 117.56MSEC XBRL filing
- Cost of revenue (annual): USD 4.76MSEC XBRL filing
- Long-term debt (annual): USD 4.59BSEC XBRL filing
- Revenue (annual): USD 385.55MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 2SEC XBRL filing
- Operating income (annual): USD 100.9MSEC XBRL filing